Genexine Balance Sheet Health
Financial Health criteria checks 5/6
Genexine has a total shareholder equity of ₩296.9B and total debt of ₩67.3B, which brings its debt-to-equity ratio to 22.7%. Its total assets and total liabilities are ₩376.6B and ₩79.7B respectively.
Key information
22.7%
Debt to equity ratio
₩67.26b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩64.48b |
| Equity | ₩296.90b |
| Total liabilities | ₩79.68b |
| Total assets | ₩376.59b |
Financial Position Analysis
Short Term Liabilities: A095700's short term assets (₩92.2B) exceed its short term liabilities (₩54.5B).
Long Term Liabilities: A095700's short term assets (₩92.2B) exceed its long term liabilities (₩25.2B).
Debt to Equity History and Analysis
Debt Level: A095700's net debt to equity ratio (0.9%) is considered satisfactory.
Reducing Debt: A095700's debt to equity ratio has increased from 13.7% to 22.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A095700 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A095700 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 8.9% each year.